Compare Illumina, Inc. (ILMN) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Eli Lilly And Co — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Eli Lilly And Co trades at $1,212.22 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 37.1× Illumina, Inc.'s market cap, and Eli Lilly And Co pays a 0.57% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | LLY | |
|---|---|---|
Market Cap | $29.12B | $1.08T |
Sector | Health | Health |
52-Week High | $205.10 | $1.24K |
52-Week Low | $91.00 | $639.43 |
Enterprise Value | $30.48B | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
